Form 4: TechPrecision Corp Director Andrew Levy Receives Restricted Stock Award

Sentiment:

SEC Form 4 Filing


Director Andrew Levy received 13,720 shares of restricted stock from TechPrecision Corporation on January 24, 2025, which will vest on December 19, 2025.

Summary

  • Andrew Levy, a director of TechPrecision Corporation, received 13,720 shares of restricted stock on January 24, 2025.
  • The shares were awarded as restricted stock and will vest in full on December 19, 2025, subject to the conditions of the award.
  • Following the transaction, Levy directly owns 427,943 shares of TechPrecision Corp common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Positives

  • The grant of restricted stock to a director aligns their interests with those of the shareholders.
  • The director's holdings in the company have increased.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Stakeholder Impact

  • Shareholders may view the grant of restricted stock as a positive sign, aligning the director's interests with the company's long-term success.

Key Dates

DateDescription
01/24/2025Date of transaction: Andrew Levy received 13,720 shares of restricted stock.
12/19/2025Vesting date for the 13,720 shares of restricted stock.
01/28/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.